Financial Result for the Quarter and year ended on March 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Trident Texofab Limited reported its audited standalone results for FY25, with revenue from operations rising to Rs. 12,205.62 lakhs from Rs. 9,948.34 lakhs in FY24, a growth of about 22.7%. Profit after tax jumped sharply to Rs. 251.01 lakhs (FY24: Rs. 107.98 lakhs), up roughly 132%. Q4 FY25 alone saw revenue of Rs. 3,820.63 lakhs (vs Rs. 3,017.12 lakhs in Q4 FY24) and a PAT of Rs. 51.05 lakhs, compared to a small loss of Rs. 10.25 lakhs in the year-ago quarter. The statutory auditor, Shah Kailash & Associates LLP, issued an unmodified opinion on the results. The Board also approved the conversion of 4,50,477 warrants into equity shares at Rs. 70 each, raising about Rs. 2.37 crore, taking paid-up equity capital to Rs. 14.51 crore (1.45 crore shares). Additionally, M/s. Purushottam Khandelwal & Co. was appointed as Internal Auditor for FY25-26.
Strong topline and bottomline growth, return to profitability in Q4, and a clean audit opinion are positive signals for shareholders. The warrant conversion causes minor equity dilution but also brings in fresh capital, supporting business expansion.